These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1757473)
1. Quantitative variations in gene expression: possible role in cellular diversification and tumor progression. Nicolson GL J Cell Biochem; 1991 Aug; 46(4):277-83. PubMed ID: 1757473 [TBL] [Abstract][Full Text] [Related]
2. Gene expression, cellular diversification and tumor progression to the metastatic phenotype. Nicolson GL Bioessays; 1991 Jul; 13(7):337-42. PubMed ID: 1759975 [TBL] [Abstract][Full Text] [Related]
3. Metastasis-Associated genes and metastatic tumor progression. Nicolson GL; Moustafa AS In Vivo; 1998; 12(6):579-88. PubMed ID: 9891220 [TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Nicolson GL Curr Opin Oncol; 1991 Feb; 3(1):75-92. PubMed ID: 2043698 [TBL] [Abstract][Full Text] [Related]
5. Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties. Nicolson GL; Gallick GE; Spohn WH; Lembo TM; Tainsky MA Oncogene; 1992 Jun; 7(6):1127-35. PubMed ID: 1594244 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis-associated genes: role in tumour progression to the metastatic state. Nicolson GL Biochem Soc Symp; 1998; 63():231-43. PubMed ID: 9513727 [TBL] [Abstract][Full Text] [Related]
8. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Nicolson GL Cancer Res; 1987 Mar; 47(6):1473-87. PubMed ID: 3545445 [TBL] [Abstract][Full Text] [Related]
9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
13. Oncogene transformation and the metastatic phenotype. Chambers AF; Tuck AB Anticancer Res; 1988; 8(5A):861-71. PubMed ID: 3052258 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors. Spandidos DA Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595 [TBL] [Abstract][Full Text] [Related]
16. An experimental model for oncogene activation during tumor progression in vivo. Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Cosma GN; Sawey MJ Anticancer Res; 1989; 9(5):1439-46. PubMed ID: 2686538 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy. Spandidos DA; Liloglou T; Field JK Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905 [TBL] [Abstract][Full Text] [Related]